Offer - Urjas Oil for just ₹ 1 X
Otosap N Ear Drop is an allopathic medicine The correct dosage of Otosap N Ear Drop depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Otosap N Ear Drop is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Otosap N Ear Drop safe for pregnant women?
Pregnant women can consume [medicine]. Though Otosap N Ear Drop has mild side effects when taken during pregnany
Is the use of Otosap N Ear Drop safe during breastfeeding?
Breastfeeding women can take Otosap N Ear Drop as it bears very minor side effects for them.
What is the effect of Otosap N Ear Drop on the Kidneys?
Otosap N Ear Drop may have mild side effects on the kidneys.
What is the effect of Otosap N Ear Drop on the Liver?
Otosap N Ear Drop is rarely harmful for the liver.
What is the effect of Otosap N Ear Drop on the Heart?
Side effects of Otosap N Ear Drop rarely affect the heart.
Otosap N Ear Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Otosap N Ear Drop unless your doctor advises you to do so -
Is this Otosap N Ear Drop habit forming or addictive?
Otosap N Ear Drop is not addictive in nature.
Interaction between Food and Otosap N Ear Drop
Taking Otosap N Ear Drop with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Otosap N Ear Drop
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Otosap N Ear Drop.
Otosap N Ear Drop is a broad-spectrum antibiotic, active against both Gram-positive and Gram-negative bacteria. It works by stopping the production of proteins that bacteria need to survive. It is effective against different types of bacteria such as Escherichia coli, Haemophilus influenza, Proteus species, S. aureus, and Serratia species. Pseudomonas aeruginosa is generally resistant.
Yes, Otosap N Ear Drop has been reported to cause diarrhea and it is a common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing diarrhea after taking this drug, consult your doctor immediately without any further delay.
Yes, Topical Otosap N Ear Drop, a cream containing a combination of neomycin and fluocinolone is used in the treatment of eczema.
Yes, Otosap N Ear Drop is safe to use, if taken in a prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as decreased urination, itching, irritation, and hearing loss. If you experience the above-mentioned side after consuming this medicine then inform your doctor and follow his/her instructions.
Otosap N Ear Drop is a brand name of neomycin. It is a prescription drug that belongs to the class of drugs called aminoglycoside antibiotics. It is a broad spectrum antibiotic which is used for treating bacterial infections especially infections of skin and eye. It is also used to treat hepatic encephalopathy.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-139
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neo-Fradin (neomycin sulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 729-730
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775